MHRA launches new action plan to combat UK counterfeit hub
The UK has become an unlikely hub for drug counterfeiters, with the UK Medicines and Healthcare products Regulatory Agency (MHRA) last week launching its new three-year action plan to tackle the recent surge in drug fakes head on.
While drug counterfeiters tend to manufacture their illegitimate wares in locations such as China or India, the UK has become a key hub for drug fakers as they realise that the presence of a British stamp on their packages adds credibility to their operations.
By Anna Lewcock
26 November 2007